Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
P W PistersM F Brennan

Abstract

To identify specific independent adverse clinicopathologic factors for event-free survival in a cohort of consecutively treated patients with extremity soft tissue sarcomas. Prospectively collected data from a population of 1,041 adult patients with localized (American Joint Committee on Cancer [AJCC] stage IA to IIIB) extremity soft tissue sarcomas were analyzed. Patients were treated at a single institution between 1982 and 1994. Patient, tumor, and pathologic factors were analyzed by univariate and multivariate techniques to identify independent prognostic factors for the end points of local recurrence, distant recurrence, disease-specific survival, and post-metastasis survival. The 5-year survival rate for this cohort of patients was 76%, with a median follow-up time of 3.95 years. Significant independent adverse prognostic factors for local recurrence were age greater than 50 years, recurrent disease at presentation, microscopically positive surgical margins, and the histologic subtypes fibrosarcoma and malignant peripheral-nerve tumor. For distant recurrence, intermediate tumor size, high histologic grade, deep location, recurrent disease at presentation, leiomyosarcoma, and nonliposarcoma histology were independent adver...Continue Reading

Citations

Feb 1, 1997·Acta Orthopaedica Scandinavica. Supplementum·A Rydholm
Aug 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M T BalloR A Pollack
Jul 14, 1999·Seminars in Surgical Oncology·J P WylieE Gutierrez
Dec 20, 1999·The Australian and New Zealand Journal of Surgery·J W SerpellM Donnovan
Nov 30, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S L SpuntA S Pappo
Aug 10, 2000·The British Journal of Surgery·M F Brennan
Feb 24, 2001·Annals of Surgical Oncology·I HoeberJ M Thomas
Jul 4, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F C EilberF R Eilber
Jul 18, 2001·Annals of Surgical Oncology·A StojadinovicM F Brennan
Feb 28, 2002·The Journal of Bone and Joint Surgery. American Volume·Akira KawaiHajime Inoue
Mar 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kaled M AlektiarMurray F Brennan
Apr 16, 2002·Clinical Orthopaedics and Related Research·Lorraine G ShapeeroJohan L Bloem
Jul 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Clemens-M WendtnerRolf D Issels
Sep 5, 2002·Cancer·Patrick P LinAlan W Yasko
May 8, 2003·Annals of Surgical Oncology·Jonathan B KoeaMurray F Brennan
Jul 23, 2003·Current Opinion in Oncology·Stephen R Grobmyer, Murray F Brennan
Oct 31, 2003·Current Treatment Options in Oncology·Alexandria Phan, Shreyaskumar Patel
Jul 28, 2004·Plastic and Reconstructive Surgery·John Y KimDavid W Chang
May 29, 2004·Annals of Surgery·Charles ChaMurray F Brennan
Nov 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Janice N CormierPeter W T Pisters
Mar 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrea FerrariFranca Fossati-Bellani
Mar 24, 2005·Journal of Surgical Oncology·Charles R Scoggins, Raphael E Pollock
Apr 14, 2005·Annals of Surgical Oncology·Fritz C EilberSamuel Singer
Dec 24, 2005·Annals of Surgical Oncology·Marco FioreAlessandro Gronchi
Jun 10, 2005·ANZ Journal of Surgery·Mark Clayer
Feb 21, 2006·Skeletal Radiology·Glen A ToomayanBrian E Brigman
Dec 22, 2006·Cancer·Patrick P LinAlan W Yasko
May 16, 2006·Cancer·Peter C FergusonJay S Wunder
Nov 24, 2006·Der Orthopäde·H RechlR Gradinger
Nov 30, 2006·Langenbeck's Archives of Surgery·Moritz N WenteMarkus W Büchler
Mar 16, 2007·Annals of Surgical Oncology·John A AbrahamSam S Yoon
Dec 13, 2006·Cancer·Catarina SvarvarUNKNOWN Scandinavian Sarcoma Group Leiomyosarcoma Working Group
Jan 27, 2007·Current Oncology Reports·Rolf D IsselsLars H Lindner
Aug 19, 2007·The British Journal of Surgery·M SampoC Blomqvist
Apr 20, 2007·Journal of Surgical Oncology·Andrew McKayRandy Moore
Jun 2, 2007·Cancer·Taimur SherAna M Gonzalez-Angulo
Jun 4, 2008·Annals of Surgical Oncology·G LahatR E Pollock
Oct 31, 2008·ANZ Journal of Surgery·Dixon T S Woon, Jonathan W Serpell
Jul 29, 2009·Clinical Orthopaedics and Related Research·David M KingGuillermo F Carrera
Dec 22, 2009·Annals of Plastic Surgery·Pentscho PopovErkki Tukiainen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.